Associations between perfluoroalkyl substances and multiple sclerosis in U.S. cohorts compared with NMOSD, MOGAD, and healthy controls

2026-05-29T13:19:23-05:00

Decode contributed transcriptomic analysis and a portion of the expression cohort to this collaborative study linking serum PFHxS and PFOA exposure to multiple sclerosis risk in females. With the University of Miami Miller School of Medicine.

Associations between perfluoroalkyl substances and multiple sclerosis in U.S. cohorts compared with NMOSD, MOGAD, and healthy controls2026-05-29T13:19:23-05:00

Genome Biology: ImmuSeeker: deep mining of immune-related gene family signatures through lineage reconstruction

2026-04-08T17:28:06-05:00

First tool to extract immune gene family signatures - including HLA and KIR activity, diversity, and binding - from standard sequencing data, validated in MS and neuromyelitis optica cohorts across eight institutions.

Genome Biology: ImmuSeeker: deep mining of immune-related gene family signatures through lineage reconstruction2026-04-08T17:28:06-05:00

The Journal of Molecular Diagnostics: Development of an End-to-End Total RNA Sequencing Quality Control Framework for Blood-Based Biomarker Discovery

2026-03-19T19:47:07-05:00

Establishes the QC methodology that underpins Decode's RNA biomarker discovery pipeline. Companion to the Agilent Technologies webinar.

The Journal of Molecular Diagnostics: Development of an End-to-End Total RNA Sequencing Quality Control Framework for Blood-Based Biomarker Discovery2026-03-19T19:47:07-05:00

The Journal of Molecular Diagnostics: Machine Learning Analysis Using RNA Sequencing to Distinguish Neuromyelitis Optica from Multiple Sclerosis and Identify Therapeutic Candidates

2026-03-20T14:38:45-05:00

Quest Diagnostics and NIH/NIAID-funded study demonstrating RNA-seq-based ML classification of NMO vs. MS, with identification of actionable therapeutic targets.

The Journal of Molecular Diagnostics: Machine Learning Analysis Using RNA Sequencing to Distinguish Neuromyelitis Optica from Multiple Sclerosis and Identify Therapeutic Candidates2026-03-20T14:38:45-05:00
Go to Top